Skip to main content

Syngenta grows strongly and stays true to Basel

| News

Syngenta grows strongly and stays true to Basel

18.06.2020

Syngenta AG, Adama and Sinochem are to be united under the umbrella of the new Syngenta Group. The group is headquartered in Basel and employs around 48,000 staff across over 100 countries.

Syngenta headquarter in Basel (img: Syngenta)

The agricultural group Syngenta is still staying true to its roots in Basel even after the takeover by Chemchina, as the newly founded Syngenta Group will be headquartered there. In addition to the former Syngenta AG, the group also comprises Adama from Israel and the agricultural business of Sinochem, which is based in China.

Syngenta Group started operating on Thursday according to a press release. The three companies are being connected to create a much larger group. Last year Syngenta, Adama and Sinochem achieved sales of 23 billion US dollars. In comparison, when Chemchina took on Syngenta in 2017 for 43 billion US dollars, the company had achieved sales of just under 13 billion dollars.

According to its own information, Syngenta Group is now the global market leader in crop protection, third place for seeds, and the market leader for fertilizers in China. Overall, it employs 48,000 staff in more than 100 countries.

Erik Fyrwald, former CEO of Syngenta AG, will head up the new group as CEO. He says: “I am pleased that our new organization is ready to bring the diversity and expertise of our teams to deliver the broadest range of sustainable and competitive products.” He goes on to say that the individual business units will be “enhanced” by the collaboration within the group.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.